GO and KEGG analysis of the intersection genes of compounds and targets showed that the EBR affected phosphorylation metabolism, negative regulation of apoptosis, and participated in pathways in cancer, PI3K-Akt signaling pathway, MAPK signaling pathway, and EGFR tyrosine kinase inhibitor resistance and were ranked at the top. The gene discussed is AKT1; the disease is cancer.